Michaela Feuring‐Buske

Author

Also Known As

Feuring-Buske M., M Feuring-Buske, M. Feuring-Buske, M. Feuring‐Buske, M. Feuring–Buske, Michaela Feuring-Buske, Michaela Feuring‐Buske

144

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München University Hospital Ulm Universität Ulm BC Cancer Agency University of Göttingen

About

Michaela Feuring‐Buske is an author at Ludwig-Maximilians-Universität München specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	2.8K
2	Health Sciences	9	9	1.8K
3	Natural Sciences	1	1	57
4	Biomedical Engineering	1	1	17
5	Biomolecular Engineering	1	1	309

Michaela Feuring‐Buske

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele, Blood Mixed-phenotype Acute LeukemiaPathologyMeasurable Residual DiseaseMyeloid NeoplasiaHematological Malignancy	2021	666
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group Peter Borchmann, Helen Goergen, Carsten Kobe, The Lancet Positron Emission TomographyAdvanced-stage HodgkinLymphoid NeoplasiaSurgical OncologyOncologic Imaging	2017	372
Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications Sabyasachi Chakrabortty, Bikram Keshari Agrawalla, Anne Stumper, Journal of the American Chemical Society Organelle-targeted PhotosensitizationNanomedicineProtein-ruthenium PhotosensitizerPhotochemistryPhotodynamic Therapy	2017	309
The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice Christina Schessl, Vijay P.S. Rawat, Monica Cusan, Journal of Clinical Investigation Hematological MalignancySystems BiologySignal TransductionSignal Transduction PathwaysMedicine	2005	240
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations D. Haase, Michaela Feuring‐Buske, Stephanie Könemann, Blood	1995	152
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1 Nicolas Pineault, Christian Buske, Michaela Feuring‐Buske, Blood	2003	147
Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia Aniruddha J. Deshpande, Monica Cusan, Vijay P.S. Rawat, Cancer Cell Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaImmunology	2006	125
A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis Konstantin Petropoulos, Natalia Arseni, Christina Schessl, The Journal of Experimental Medicine	2008	121
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38− progenitor cells from patients with acute myeloid leukemia Michaela Feuring‐Buske, Donna E. Hogge Blood	2001	118
A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors. Michaela Feuring‐Buske, Arthur E. Frankel, Richard Alexander, PubMed Cell TherapyImmunotoxicologyImmunologyPathologyCell Death	2002	113

Page 1